← FDA DRUG APPROVALS

FDA ANDA · ANDA214072

TENOFOVIR ALAFENAMIDE

Sponsor: SHILPA MEDICARE LTD

APPLICATION
ANDA214072
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)

Products

TENOFOVIR ALAFENAMIDENone (Tentative Approval)
TENOFOVIR ALAFENAMIDE 25MG · TABLET · ORAL

Approval history

2022-09-15UNKNOWN · Original · standardLetterTA
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →